Investigations into factors determining the duration of action of the beta 2-adrenoceptor agonist, salmeterol.
about
The interaction between salmeterol and beta 2-adrenoceptor agonists with higher efficacy on guinea-pig trachea and human bronchus in vitro.Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms.Influence of receptor number on the stimulation by salmeterol of gene transcription in CHO-K1 cells transfected with the human beta2-adrenoceptorAtypical responses of rat ileum to pindolol, cyanopindolol and iodocyanopindolol.Extent of salmeterol-mediated reassertion of relaxation in guinea-pig trachea pretreated with aliphatic side chain structural analogues.Effect of salmeterol on human nasal epithelial cell ciliary beating: inhibition of the ciliotoxin, pyocyanin.Molecular mechanisms for the persistent bronchodilatory effect of the beta 2-adrenoceptor agonist salmeterolAgonist-specific patterns of beta 2-adrenoceptor responses in human airway cells during prolonged exposure.Salmeterol.Tracheal relaxing effects and beta2 adrenoceptor selectivity of S1319, a novel sponge-derived bronchodilator agent, in isolated guinea-pig tissues.Correlation of cyclic AMP accumulation and relaxant actions of salmeterol and salbutamol in bovine tracheal smooth muscle.The duration of action of non-beta 2-adrenoceptor mediated responses to salmeterol.Effects of salmeterol and terbutaline on IgE-mediated dermal reactions and inflammatory events in skin chambers in atopic patients.Effects of beta-adrenoceptor agonists in human bronchial smooth muscle.G Protein-Coupled Receptor Endocytosis Confers Uniformity in Responses to Chemically Distinct Ligands.Detection and pharmacokinetics of salmeterol in thoroughbred horses following inhaled administration.
P2860
Q34793535-BD0352F8-2CFB-403D-A4CF-D6042EC9F820Q35027302-077B88FC-2C32-4450-AF69-E7714009821CQ35040807-154C754A-BBBA-463E-976F-B1FE5B85623BQ35873324-5A90C985-D2A6-4CCF-B91A-441FFBAF43BEQ35873966-1BCCD53B-ED47-41DD-AA96-EEA1B1398AD5Q35874799-AE686999-4BAA-4678-B62B-F6C579EEDF6DQ39826205-C2E08F00-0CC4-4295-8CA5-4FBFC94B5E24Q39832616-D57C1B90-9321-42B0-9760-2DBDB1D08728Q40473337-793D3331-1DFE-49A4-83A6-8D109E190623Q41957152-42593B73-60B3-479D-8864-1B3904590948Q41980233-58910298-405D-4B9E-B109-303B7762973FQ42156419-06482BEE-6AB9-4F52-B739-9C0B47A2A0E7Q42552724-1D2640E8-68A2-4463-8856-8A1C05B59773Q42920735-3D50E444-E046-4D76-A414-13A6E949281AQ46308914-44CDEA42-07F3-494D-AEA4-6B1B778B5334Q50948358-09C6B20F-4296-46A2-8F0E-1A92BC736EF0
P2860
Investigations into factors determining the duration of action of the beta 2-adrenoceptor agonist, salmeterol.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Investigations into factors de ...... enoceptor agonist, salmeterol.
@ast
Investigations into factors de ...... enoceptor agonist, salmeterol.
@en
type
label
Investigations into factors de ...... enoceptor agonist, salmeterol.
@ast
Investigations into factors de ...... enoceptor agonist, salmeterol.
@en
prefLabel
Investigations into factors de ...... enoceptor agonist, salmeterol.
@ast
Investigations into factors de ...... enoceptor agonist, salmeterol.
@en
P2093
P2860
P1476
Investigations into factors de ...... enoceptor agonist, salmeterol.
@en
P2093
P2860
P304
P356
10.1111/J.1476-5381.1993.TB12833.X
P407
P577
1993-02-01T00:00:00Z